Dialysis patients experience 10–20 times higher cardiovascular mortality than the general
population. The high burden of both conventional and nontraditional risk factors attributable …

Background: Left ventricular diastolic dysfunction (LVDD) is observed in the early stages of
chronic kidney disease (CKD) and may lead to heart failure with preserved ejection fraction …

Objective Volume overload is a frequent feature related to left ventricular hypertrophy (LVH)
in dialysis patients, but its influence on patients with chronic kidney disease (CKD) not on …

Background and Objectives: N-terminal pro-brain natriuretic peptide (NT-proBNP) is a
biomarker used to predict heart failure and evaluate volume status in hemodialysis (HD) …

Background The pathophysiological mechanism of cardiovascular disease in patients with
chronic kidney disease (CKD) is complicated. Mediation analysis is an important statistical …

Background: Hypervolemia is thought to be a major contributor to higher left ventricular
mass (LVM), a potent predictor for cardiovascular mortality among patients on maintenance …

Background Intradialytic hypertension, defined as an increase in BP from pre-to post-
hemodialysis (HD), affects 5%–15% of patients receiving maintenance HD and is associated …

Objective: To ascertain the effect of duration of hemodialysis on left ventricular hypertrophy
in patients with chronic kidney disease. Design: It was a cross sectional observational study …

Background: Patients with end stage renal disease under hemodialysis are at increased risk
for morbidities and mortality. Cardiovascular diseases are independent risk for death among …

Many patients on dialysis are older adults with numerous comorbid conditions and poor
nutritional health. Improving fluid and nutritional status are major treatment goals for patients …